The purpose of this study was to compare CUS findings with those of CXR in children with presumptive PTB. More children had an abnormal finding on CXR than on CUS, but the reverse was true for those with a likelihood of TB. There was no significant difference in finding consolidations and pleural effusions between CUS and CXR, unlike lymphadenopathy. When the reading of these features was compared between CUS and CXR, there was a moderate inter-reader agreement for consolidations and pleural effusions, but only a slight inter-reader agreement for lymphadenopathy.
Slightly more pleural effusions were detected on CUS (20%) than on CXR (13.75%), but the difference was not statistically significant (P = 4.07). This is comparable to the literature that reported CUS to be superior in detecting pleural effusion compared to CXR [6, 15, 16]. Pleural effusion is more likely to be associated with TB on both CXR and CUS, although pleural effusion can occur in children with pneumonia caused by other bacteria (pneumococcus and Staphylococcus) or viruses [6]. However, these children are usually younger and acutely unwell compared to children with pleural effusion due to TB [17]. PTB is a probable diagnosis when pleural effusion is present, especially if there is consolidation.
The presence of consolidation was associated with the likelihood of TB on both the CUS and CXR. Consolidation is commonly seen in children with pulmonary TB. However, it has also been observed in children with bacterial infections and less commonly, viral pneumonia. “Co-infection” was also common, where children with underlying pulmonary TB present co-infected with viral or bacterial pneumonia [17]. We encourage radiologists and clinicians in the presence of consolidation to look for other features, especially pleural effusion.
Less lymphadenopathy was detected on CUS than on CXR. This contrasts with the available literature, which reported more lymphadenopathy in CUS than in CXR [6, 10]. Lymphadenopathy with or without parenchymal abnormalities is the radiological hallmark of primary TB in children. This is often more prevalent in children aged < 3 years than in those between 4-and 15 years [18]. Since lymphadenopathy, especially in the mediastinal region, is likely to be the only feature of CXR, CUS efforts should be made to look for it in presumptive TB patients, especially those less than 3 years of age.
This study has key implications for clinical practice, especially in the management of children with suspected TB, using ultrasonography as a screening tool. CUS can detect some features suggestive of TB in children, and it has the potential to be used as an initial modality before children are exposed to chest x-rays with ionizing radiation. CUS has become even more useful in rural and remote healthcare settings where x-ray equipment is not available. Thus, we encourage the screening of suspected children in these settings initially with CUS.
This study compared the findings of CUS to CXR. Ideally, we should have compared CUS with Computer Tomography (CT) and Magnetic Resonance and Imaging (MRI), which are the gold standard for imaging. However, Chest CT scan has very high radiation dose making it not a first line imaging modality in children who have radiosensitive tissues. MRI scans are few and very expensive in the setting where the study took place. Despite this, however, the study does provide useful indicators that CUS can be used as an initial screening tool for children suspected to have TB and aid in identifying which ones require further imaging and management. Moving forward there is need for comparing the additional benefit of using CUS to diagnose TB in children earlier.